Niemann-Pick type C patient database and genetic data study
Part of Blood & lymphatic, Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study collects health information and genetic samples from people diagnosed with Niemann-Pick disease type C. The goal is to build a large database that can help researchers better understand the condition and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be willing to sign and date a consent form
- Be able and willing to follow study steps and stay in the study for its full duration
- Have a diagnosis of Niemann-Pick disease type C using clinical, lab, or genetic (molecular) testing
- Be able to provide a DNA sample (a required biospecimen)
- Be able to share medical records or other clinical data
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures biochemical (blood/biologic) markers and may use clinical evaluation and MRI to better understand Niemann-Pick disease type C. It could help improve how the condition is tracked and understood over time.
This Phase 3 trial tests whether N-acetyl-leucine can improve symptoms in people with Niemann-Pick disease type C (NPC). If you qualify, you will be asked to take study medicine and complete symptom and movement tests over time.
This study helps collect information and provide certain clinical care and interventions for people who come to the National Cancer Institute (NCI) Clinical Center (CCR). It may be a fit if you need NCI-level evaluation or support because your condition is complex, or if you’re involved as a cellular therapy donor or certain family members needing genetic testing.
This is an observational study that collects health and family history information to see how advanced data analysis can help people with genetic conditions. It may involve website forms, optional conversations, and sometimes an NIH visit, depending on your situation.
This study looks at people with CLN3 and other related forms of NCL (a childhood brain-wasting illness) to better describe symptoms and disease changes over time. You may be followed with regular check-ins, medical records, and sometimes NIH visits or sample collection.
This study looks for genetic causes of immune problems, such as unusually frequent infections, abnormal allergies, or autoimmune or inflammation conditions. It may help by improving how doctors understand these disorders and by matching families with possible genetic diagnoses.
Hear when a new Niemann-Pick Disease, Type C trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.